David G Armstrong
Overview
Explore the profile of David G Armstrong including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
479
Citations
11686
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Armstrong D, Najafi B, Gao W, Klonoff D, Liu C
J Diabetes Sci Technol
. 2025 Mar;
:19322968251326906.
PMID: 40088132
No abstract available.
2.
Brooks L, Brooks B, Arp A, Dove C, Rogers L, Michel R, et al.
Semin Vasc Surg
. 2025 Mar;
38(1):94-100.
PMID: 40086927
Of the roughly 38 million people diagnosed with type 2 diabetes mellitus in the United States, up to 34% will develop a diabetic foot ulcer at some point, up to...
3.
Kayssi A, Minc S, Armstrong D
Semin Vasc Surg
. 2025 Mar;
38(1):1-2.
PMID: 40086915
No abstract available.
4.
Armstrong D, Kruse D, Carter M, Zelen C, Isaac A
Wounds
. 2025 Mar;
37(2):56-62.
PMID: 40053422
Background: Considering the rising incidence and cost associated with chronic wounds, further investigation of safe and effective treatments is needed. Objective: To conduct a retrospective analysis of patients with chronic...
5.
6.
Armstrong D, Hanft J, Surprenant M, Isaac A, Carter M, Zelen C, et al.
Cureus
. 2025 Jan;
17(1):e78021.
PMID: 39872922
The increased cost and morbidity associated with diabetic foot ulcers (DFUs) place a substantial strain on the entire global healthcare system. In this trial, 24 subjects with a chronic DFU,...
7.
Luu I, Hong A, Lee A, Arias J, Shih C, Armstrong D, et al.
Diabetology (Basel)
. 2025 Jan;
5(5):491-500.
PMID: 39777036
Objectives: This study aims to examine the association between state Medicaid coverage of podiatry services and the outcomes of beneficiaries with new diabetic foot ulcers (DFUs). Methods: Medicaid beneficiaries who...
8.
Yang Z, Yang M, Rui S, Hao W, Wu X, Guo L, et al.
Heliyon
. 2024 Nov;
10(20):e39251.
PMID: 39498056
Diabetic foot ulcers (DFUs) represent a serious complication of diabetes with high incidence, requiring intensive treatment, prolonged hospitalization, and high costs. It poses a severe threat to the patient's life,...
9.
Kwon K, Brown T, Arias Aristizabal J, Armstrong D, Tan T
Diabetology (Basel)
. 2024 Nov;
5(3):356-364.
PMID: 39483486
Objective: This study investigates the outcomes of Medicaid beneficiaries with diabetic foot ulcers (DFUs) who had transitioned to commercial insurance. Methods: We utilized the PearlDiver claims database to identify adult...
10.
Meloni M, Colboc H, Armstrong D, Dissemond J, Rayman G, Lazaro-Martinez J, et al.
J Wound Care
. 2024 Oct;
33(10):756-770.
PMID: 39388207
Objective: Several national and international guidelines recommend lipidocolloid technology with a nano-oligosaccharide factor (TLC-NOSF) dressings (UrgoStart dressing range, Laboratoires Urgo, France) for treating patients with chronic wounds. However, these dressings...